The New FDA: Product Development, Pricing and Beyond

RopesTalk
20/12/2016 6 min
The New FDA: Product Development, Pricing and Beyond

Listen "The New FDA: Product Development, Pricing and Beyond"

Descargar episodio Ver en sitio original

Episode Synopsis


What impact will the incoming Trump administration have on the 2017 health care and life sciences regulatory outlook? In this podcast, Washington, D.C.-based partners Tom Bulleit (health care) and Al Cacozza (life sciences) offer their perspectives on what might lie ahead.

More episodes of the podcast RopesTalk

Alumni @ RopesTalk: Conversation with Steven Obiajulu, UseJunior 22/09/2025
Culture & Compliance Chronicles: Lawyering with Purpose—Human Rights, Culture & Social Responsibility with Archana Kotecha 17/09/2025
Expanding Access to Alternative Investments in ERISA Plans—Litigation Risks and Practical Considerations 10/09/2025
From Chaos to Clarity: Real-World Lessons in Navigating Corporate Crises 04/09/2025
Multidimensional Data Reversion: From Search Terms to GenAI—How We Got Here and What We Learned Along The Way 27/08/2025
Restoring Integrity: Leadership Strategies in Times of Crisis 21/08/2025
Mentorship, Growth & Opportunity: Experiences from the 2025 Summer Associate Program 13/08/2025
Culture & Compliance Chronicles: Beyond Bad Apples—How Context Shapes Corporate Misconduct with Professor Guido Palazzo 13/08/2025
Talkin' Trade: Unpacking Recent ITC Trade Secret Misappropriation Case Law 07/08/2025
Navigating Non-Competes and Other Exclusivity Provisions in Collaboration & License Agreements and Other Strategic Transactions in Light of EU Competition Laws 04/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA